## Prevention of MH Crisis in Susceptible Patients ### Risk Stratification **Key Point:** Family history of MH or unexplained perioperative death/complications in relatives = presumed MH susceptibility until proven otherwise. These patients require a non-triggering anesthetic technique. **High-Yield:** MH susceptibility is inherited in an autosomal dominant pattern with variable penetrance (mutations in RYR1 ~70%, CACNA1S ~20%). A positive family history warrants avoidance of ALL volatile anesthetics and succinylcholine. ### Classification of Anesthetic Agents | Agent Category | Triggering? | Safe in MH? | Examples | |---|---|---|---| | **Volatile anesthetics** | YES | NO | Isoflurane, desflurane, sevoflurane, halothane | | **Depolarizing agents** | YES | NO | Succinylcholine | | **IV induction agents** | NO | YES | Propofol, thiopental, etomidate, ketamine | | **Non-depolarizing NMBs** | NO | YES | Rocuronium, vecuronium, cisatracurium, atracurium | | **Opioids** | NO | YES | Fentanyl, remifentanil, morphine | | **Benzodiazepines** | NO | YES | Midazolam | | **Nitrous oxide** | NO | YES | N₂O | | **Local anesthetics** | NO | YES | Lidocaine, bupivacaine | **Clinical Pearl:** Nitrous oxide is NOT triggering and is safe in MH-susceptible patients. However, modern practice often avoids N₂O due to other concerns (PONV, neurotoxicity); TIVA is preferred. ### Optimal Non-Triggering Technique (TIVA) ```mermaid flowchart TD A["MH-Susceptible Patient"]:::outcome --> B["Induction: Propofol or Etomidate IV"]:::action B --> C["Intubation: Non-depolarizing NMB<br/>Rocuronium or Vecuronium"]:::action C --> D["Maintenance: TIVA<br/>Propofol + Remifentanil"]:::action D --> E["Avoid ALL volatile anesthetics"]:::urgent E --> F["Avoid succinylcholine"]:::urgent F --> G["Safe alternatives:<br/>N₂O + TIVA acceptable"]:::action G --> H["Monitor: ETCO₂, temp, K⁺"]:::action H --> I["Dantrolene on standby in OR"]:::action ``` ### Why TIVA (Total Intravenous Anesthesia) is Gold Standard 1. **Propofol** (induction and maintenance) — non-triggering, rapid offset, antiemetic. 2. **Remifentanil** (opioid infusion) — ultra-short acting, allows rapid emergence. 3. **Non-depolarizing NMB** (rocuronium or vecuronium) — safe, no triggering. 4. **Nitrous oxide** (optional) — safe but often omitted in modern TIVA. **Mnemonic: "TIVA = Total Intravenous Anesthesia = Trigger-free Anesthesia"** - **T**otal = all drugs IV, no volatile - **I**ntravenous = propofol + remifentanil - **V**oid = volatile anesthetics - **A**void = succinylcholine ### Preoperative Counseling & Precautions - Inform patient of MH risk; discuss non-triggering plan. - Ensure dantrolene (36 vials, 20 mg each) is available in OR. - Use fresh CO₂ absorbent (volatile anesthetic residue can linger in old absorbent). - Have MH emergency protocol posted in OR. - Consider MH testing (caffeine halothane contracture test, genetic testing) if patient desires definitive diagnosis. **High-Yield:** Even with a non-triggering technique, maintain vigilance for signs of MH (↑ETCO₂, muscle rigidity, tachycardia, fever). MH can rarely occur with TIVA alone if patient is homozygous for RYR1 mutation, but risk is <1%. ### Why NOT the Other Options - **Option 1:** Isoflurane is a volatile anesthetic (TRIGGERING); succinylcholine is a depolarizing agent (TRIGGERING). Both are contraindicated. - **Option 3:** Desflurane is a volatile anesthetic (TRIGGERING); succinylcholine is TRIGGERING. Both contraindicated. - **Option 4:** Sevoflurane is a volatile anesthetic (TRIGGERING). Etomidate and vecuronium are safe, but the volatile agent makes this plan unsafe.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.